Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

China IND approval for Apollomics' multikinase inhibitor APL-102

Nov. 12, 2020

Metabolic pathway-based TNBC subtyping reveals potential new targets

Nov. 12, 2020

Massachusetts Institute of Technology synthesizes compounds for cancer

Nov. 12, 2020

Kuling Therapeutics patents RORC antagonists

Nov. 12, 2020

Early clinical data reported for [177Lu]rhPSMA-7.3 in mCRPC

Nov. 12, 2020

NiKang Therapeutics synthesizes new HIF-2alpha inhibitors

Nov. 11, 2020

Colorado Research Partners identifies KHK inhibitors

Nov. 11, 2020

Ariagen patents AhR agonists for cancer

Nov. 11, 2020

Study shows how mutant KRAS initiates pancreatic cancer

Nov. 10, 2020

European Commission approves Calquence for the treatment of CLL

Nov. 10, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...